相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Mohamad-Gabriel Alameh et al.
IMMUNITY (2021)
Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions
Eric M. Mucker et al.
VIROLOGY (2020)
Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines
Eric M. Mucker et al.
SCIENTIFIC REPORTS (2020)
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
Nurgun Kose et al.
SCIENCE IMMUNOLOGY (2019)
Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease
Eric M. Mucker et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Moritz Thran et al.
EMBO MOLECULAR MEDICINE (2017)
Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
Karuppiah Muthumani et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Norbert Pardi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
Andreas Thess et al.
MOLECULAR THERAPY (2015)
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Seleeke Flingai et al.
SCIENTIFIC REPORTS (2015)
Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease
Eric M. Mucker et al.
PLOS ONE (2015)
A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
Steve Kwilas et al.
CURRENT GENE THERAPY (2014)
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
Peter J. K. van Meer et al.
MABS (2013)
Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab
Kar Muthumani et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Side-by-Side Comparison of Gene-Based Smallpox Vaccine with MVA in Nonhuman Primates
Joseph W. Golden et al.
PLOS ONE (2012)
Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies
Lindsay Crickard et al.
PLOS ONE (2012)
The strategic use of novel smallpox vaccines in the post-eradication world
Joseph W. Golden et al.
EXPERT REVIEW OF VACCINES (2011)
Passive Immunotherapies Protect WRvFire and IHD-J-Luc Vaccinia Virus-Infected Mice from Lethality by Reducing Viral Loads in the Upper Respiratory Tract and Internal Organs
Marina Zaitseva et al.
JOURNAL OF VIROLOGY (2011)
Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease
Joseph W. Golden et al.
VIROLOGY JOURNAL (2011)
Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections
Yuhong Xiao et al.
VIRUSES-BASEL (2010)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model
Zhaochun Chen et al.
JOURNAL OF VIROLOGY (2007)
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus
ZC Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge
S Lustig et al.
JOURNAL OF VIROLOGY (2005)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
分享论文
